The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Adherence to Statins, Subsequent Healthcare Costs, and Cardiovascular Hospitalizations
Abstract
Statins are the primary agents used to decrease low-density lipoprotein cholesterol. Although adherence to statins improves the clinical outcomes, the affect of statin adherence on healthcare costs has not been well studied. To examine the relation among statin adherence, subsequent hospitalizations, and healthcare costs, we conducted a retrospective cohort study of 381,422 patients, aged 18 to 61 years, using an integrated pharmacy and medical claims database. We measured adherence using the medication possession ratio (MPR) for 12 months and the healthcare costs and cardiovascular disease-related hospitalizations during the subsequent 18 months. Of those studied, 258,013 (67.6%) were adherent (MPR ≥80%), 65,795 (17.3%) had an MPR of 60% to 79%, and 57,614 (15.1%) had an MPR of <60%. The adjusted all-cause total healthcare costs were lowest in the adherent group at $10,198 ± $39.4 (mean ± SE) versus $10,609 ± $77.7 (p <0.001) for an MPR of 60% to 79%, and $11,102 ± $84.3 (p <0.001) for an MPR of <60%. The adherent group had greater statin costs at $838 ± $1.0 versus $664 ± $2.0 (p <0.001) and $488 ± $2.2 (p <0.001). When evaluated by 5 levels of MPR, 0% to 59% and increments of 10% >60%, the adjusted total healthcare costs were lowest for the MPR 90% to 100% group and significantly greater statistically (p <0.001) for each lower level of adherence. Compared to the statin-adherent patients, cardiovascular disease-related hospitalizations were more likely for the patients with an MPR of 60% to 79% (odds ratio 1.12, 95% confidence interval 1.08 to 1.16) and an MPR of 0% to 59% (odds ratio 1.26, 95% confidence interval 1.21 to 1.31). In conclusion, statin adherence is associated with reductions in subsequent total healthcare costs and cardiovascular disease-related hospitalizations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,399
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Medication Adherence: Its Importance in Cardiovascular Outcomes
Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009) · Circulation · doi:10.1161/circulationaha.108.768986 · Cited by 1,488
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
Jackevicius, C. A. (2002) · JAMA · doi:10.1001/jama.288.4.462 · Cited by 1,077
Rasmussen, J. N., Chong, A., & Alter, D. A. (2007) · JAMA · doi:10.1001/jama.297.2.177 · Cited by 975
Hess, L. M., Raebel, M. A., Conner, D. A., & Malone, D. C. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h018 · Cited by 778
Ho, P. M., Magid, D. J., Shetterly, S. M., Olson, K. L., Maddox, T. M., Peterson, P. N., Masoudi, F. A., & Rumsfeld, J. S. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.12.011 · Cited by 587
Choo, P. W., Rand, C. S., Inui, T. S., Lee, M. T., Cain, E., Cordeiro-Breault, M., Canning, C. F., & Platt, R. G. (1999) · Medical Care · doi:10.1097/00005650-199909000-00002 · Cited by 546
Brookhart, M. A., Patrick, A. R., Dormuth, C. R., Avorn, J., Shrank, W. H., Cadarette, S. M., & Solomon, D. H. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm070 · Cited by 386
Suboptimal statin adherence and discontinuation in primary and secondary prevention populations
Ellis, J. J., Erickson, S. R., Stevenson, J. G., Bernstein, S. J., Stiles, R. A., & Fendrick, A. M. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.30516.x · Cited by 320
Mann, D., Reynolds, K., Smith, D. A., & Muntner, P. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l181 · Cited by 222
Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy.
Goldman, D. P., Joyce, G., & Karaca‐Mandic, P. (2006) · PubMed · Cited by 163
Schneeweiß, S., Patrick, A. R., Maclure, M., Dormuth, C. R., & Glynn, R. J. (2007) · Circulation · doi:10.1161/circulationaha.106.665992 · Cited by 132
Choudhry, N. K., Patrick, A. R., Antman, E. M., Avorn, J., & Shrank, W. H. (2008) · Circulation · doi:10.1161/circulationaha.107.735605 · Cited by 132
Factors Related to Adherence to Statin Therapy
McGinnis, B., Olson, K. L., Magid, D. J., Bayliss, E., Korner, E. J., Brand, D. W., & Steiner, J. F. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k209 · Cited by 121
Frolkis, J. P., Pearce, G. L., Nambi, V., Minor, S., & Sprecher, D. L. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01303-7 · Cited by 113
Impact of statin copayments on adherence and medical care utilization and expenditures.
Gibson, T. B., Mark, T. L., Axelsen, K. J., Baser, O., Rublee, D. A., & McGuigan, K. A. (2006) · PubMed · Cited by 110
(2010) · PubMed · Cited by 58
Comparison of measures of medication persistency using a prescription drug database
Hudson, M., Rahme, E., Richard, H., & Pilote, L. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.10.018 · Cited by 50
Pharmacoeconomic Impact of Non-Compliance with Statins
Peterson, A. M., & McGhan, W. F. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523010-00002 · Cited by 34
Cited by
Sorted by citations
Economic impact of medication non-adherence by disease groups: a systematic review
Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., & Garcia-Cardenas, V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-016982 · Cited by 900
Adherence and health care costs
McGuire, M., & Iuga, A. O. (2014) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s19801 · Cited by 779
Manteuffel, M., Williams, S., Chen, W., Verbrugge, R. R., Pittman, D. G., & Steinkellner, A. R. (2013) · Journal of Women s Health · doi:10.1089/jwh.2012.3972 · Cited by 423
Self-citationBitton, A., Choudhry, N. K., Matlin, O. S., Swanton, K., & Shrank, W. H. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.09.004 · Cited by 256
Wei, M. Y., Ito, M. K., Cohen, J. D., Brinton, E. A., & Jacobson, T. A. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.03.001 · Cited by 260
Metadata
- Authors
- Pittman, D. G., Chen, W., Bowlin, S. J., & Foody, J. M.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Pittman, Donald G.
- ORCID
- Chen, William
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 107
- Issue
- 11
- Pages
- 1662-1666
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2150048145
- Cited by
- 123
- References
- 21
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 5 · 2023: 6 · 2022: 8 · 2021: 8 · 2020: 10 · 2019: 11 · 2018: 10 · 2017: 7 · 2016: 7 · 2015: 7 · 2014: 10 · 2013: 14 · 2012: 9
- FWCI
- 10.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- statin adherence, medication possession ratio, health care costs, cardiovascular hospitalization, cardiovascular disease, LDL cholesterol, medication adherence
- MeSH terms
- Adolescent, Adult, Female, Hospitalization, Humans, Male, Middle Aged, Retrospective Studies, Health Care Costs, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review